Betacell

The science of diabetes care continues to evolve every year. Ultimately, however, that science will have no impact on health until it is translated into practice.

In considering the subject matter for my next blog, my mind wandered a bit and settled on a patient with type 2 diabetes I had seen last week. While riding her bicycle, she had suddenly felt dizzy and disoriented and side swiped a parked car.

Fatty liver disease is the most common cause of chronic liver disease in North America[1] and is becoming one of the top reasons for liver transplantation. Fatty liver causes inflammation that can lead to fibrosis, cirrhosis, and hepatocellular carcinoma.

Evidence that protecting pancreatic beta cells from chronic overstimulation to maintain glucose homeostasis has led to the concept of “beta cell rest” to preserve or restore beta cell function by temporarily inhibiting insulin secretion.

Case 2: Metformin Fails in T2DM Patient represents a clinical dilemma faced by every primary care doctor.

Do you recognize this patient?  I have seen him in my office, or a person just like him. The Center for Disease Control (CDC, HHS) estimates that 57 million people in the U.S. have pre-diabetes.